Font Size: a A A
Keyword [Antibody-drug conjugate]
Result: 1 - 18 | Page: 1 of 1
1. A Human Anti-c-Met Fab Fragment Conjugated With Doxorubicin Inhibits Hepatocellular Carcinoma Growth In Vitro And In Vivo
2. Preclinical Studies Of A Pro-antibody-drug Conjugate Designed To Selectively Target EGFR-overexpressing Tumors With Improved Therapeutic Efficacy
3. The Research Of Cetuximab Conjugated Tubulin Inhibitorin The Treatment Of Human Lung Cancer A549 Nude Mice
4. The Pharmacokinetic Study On Catabolite Of Trastuzumab-Maytansinoid
5. Identification Of PD-L1 Antibody And Preparation Of Antibody-drug Conjugate For Cancer Therapy
6. In Vitro Study Of EGFR Monoclonal Antibody Conjugate Tubulin Inhibitoson Inhibition Of Human Lung Cancer
7. The Research Of Cetuximab Conjugated Tubulin Inhibitorin Of Effectiveness And Targeting In The Treatment Of Human Lung Cancer
8. Preparation And Pharmacodynamics Research Of Antibody Drug Conjugate AC133-L1-MMAF
9. Study Of Human Anti-Prostate Specific Membrane Antigen (PSMA) Antibody-Drug Conjugates
10. The Design Of Antibody-drug Conjugates And Studies On Their Specific Antitumor Activities
11. Study Of PSMA Expression In Various Tumors And Treatment On Prostate Cancer Using PSMA-based Antibody-drug Conjugate
12. Preliminary Sduty Of Preclinical Pharmacodynamics Of Kadcyla,An Antibody-drug Conjugate
13. The Quality Research And Structure Characternation Of An Anti-humanepidermal Growth Factor Receptor-2-MCC-DM1
14. The Repeated Dose Toxicity And Immunogenticity Study Of S037 In Cynomolgus Monkey
15. Combination Of Targeted Drugs To Improve The Safty And Efficacy Of CAR T Cell Therapy
16. Preliminary Study On The Feasibility Of Tumor Specific Presented Antigens As Targets For Antibody Drugs
17. Design,Synthesis And Biological Evaluation Of Novel Antibody-Drug Conjugates With Anti-Tumor Effects
18. The Mechanisms Underlying The Synergistic Antitumor Activity Of Multi-targeted Tyrosine Kinase Inhibitor Famitinib And The Third-generation EGFR Inhibitor HS-10296 As Well As The Antitumor Activity Of The Novel Antibody-drug Conjugates Targeting CD79b
  <<First  <Prev  Next>  Last>>  Jump to